Description
Product details
GLISITAPTIN M 1000 Sitagliptin Phosphate (50mg), Metformin HCI (1000mg) Sitagliptin Phosphate (50mg) Sitagliptin Phosphate is a potent component of GLISITAPTIN M 1000, primarily used to manage blood sugar levels in individuals with type 2 diabetes. As a DPP-4 inhibitor, Sitagliptin works by increasing the levels of incretin hormones, which are involved in the regulation of glucose metabolism. These hormones enhance the production of insulin when it is needed (particularly after eating) and reduce the amount of glucose being produced by the liver when it is not needed. The inclusion of 50mg of Sitagliptin in GLISITAPTIN M 1000 ensures that patients receive a dose that is both effective and well-tolerated, making it a cornerstone of diabetes management. Its efficacy is particularly noted in its ability to improve glycemic control without promoting weight gain—a common concern among diabetes patients. Additionally, Sitagliptin has a low risk of causing hypoglycemia (low blood sugar levels), making it a safer option for long-term use. Metformin HCI (1000mg) Metformin HCI complements Sitagliptin in GLISITAPTIN M 1000 by targeting a different aspect of diabetes management. As one of the most commonly prescribed medications for type 2 diabetes, Metformin works by improving the sensitivity of body tissues to insulin, thus facilitating the effective utilization of glucose. It also decreases glucose production in the liver, contributing further to lower blood sugar levels. The dose of 1000mg of Metformin in GLISITAPTIN M 1000 is optimal for providing significant therapeutic effects while maintaining a good safety profile. It is particularly beneficial in managing the fasting plasma glucose—a critical factor in the overall control of diabetes. Metformin also offers benefits beyond glucose control, such as improving lipid profiles and contributing to slight weight loss, which is advantageous for diabetic patients who are often battling obesity. Combined Benefits in GLISITAPTIN M 1000 The combination of Sitagliptin Phosphate and Metformin HCI in GLISITAPTIN M 1000 offers a synergistic approach to managing type 2 diabetes. This dual therapy not only maximizes the control of blood sugar levels but also reduces the risk of diabetes-related complications when used consistently. The combination allows for the reduction in the dosage of each component, which minimizes potential side effects while maintaining efficacy. Moreover, GLISITAPTIN M 1000 is specifically designed to enhance patient compliance and convenience, with its once-daily dosing making it easier for patients to adhere to their treatment regimen. This is crucial in chronic conditions like diabetes, where consistent medication adherence is key to successful long-term outcomes. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 BUY NOW https://www.sterisonline.com/product/glisitaptin-m-1000-133869
